175 related articles for article (PubMed ID: 26589455)
1. Toll-like receptor 4 signaling promotes invasion of hepatocellular carcinoma cells through MKK4/JNK pathway.
Dong YQ; Lu CW; Zhang L; Yang J; Hameed W; Chen W
Mol Immunol; 2015 Dec; 68(2 Pt C):671-83. PubMed ID: 26589455
[TBL] [Abstract][Full Text] [Related]
2. LPS promotes epithelial-mesenchymal transition and activation of TLR4/JNK signaling.
Li H; Li Y; Liu D; Liu J
Tumour Biol; 2014 Oct; 35(10):10429-35. PubMed ID: 25053598
[TBL] [Abstract][Full Text] [Related]
3. A896G and C1196T Polymorphisms Within the TLR4 Gene Abate Toll-Like Receptor 4-Mediated Signaling in HepG2 Cells.
Huang C; Zhang H; Bai R; Wang L; Lv J
DNA Cell Biol; 2017 Nov; 36(11):1029-1038. PubMed ID: 28945461
[TBL] [Abstract][Full Text] [Related]
4. Toll like receptor 4 facilitates invasion and migration as a cancer stem cell marker in hepatocellular carcinoma.
Liu WT; Jing YY; Yu GF; Han ZP; Yu DD; Fan QM; Ye F; Li R; Gao L; Zhao QD; Wu MC; Wei LX
Cancer Lett; 2015 Mar; 358(2):136-143. PubMed ID: 25511737
[TBL] [Abstract][Full Text] [Related]
5. Invasion potential of H22 hepatocarcinoma cells is increased by HMGB1-induced tumor NF-κB signaling via initiation of HSP70.
Gong W; Wang ZY; Chen GX; Liu YQ; Gu XY; Liu WW
Oncol Rep; 2013 Sep; 30(3):1249-56. PubMed ID: 23836405
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide-induced toll-like receptor 4 signaling in cancer cells promotes cell survival and proliferation in hepatocellular carcinoma.
Wang L; Zhu R; Huang Z; Li H; Zhu H
Dig Dis Sci; 2013 Aug; 58(8):2223-36. PubMed ID: 23828139
[TBL] [Abstract][Full Text] [Related]
7. Glucan phosphate inhibits HMGB-1 release from rat myocardial H9C2 cells in sepsis via TLR4/NF-кB signal pathway.
Wang H; Cui Z; Sun F; Ding H
Clin Invest Med; 2017 Apr; 40(2):E66-E72. PubMed ID: 28447579
[TBL] [Abstract][Full Text] [Related]
8. Interaction of PTPRO and TLR4 signaling in hepatocellular carcinoma.
Xu D; Wang X; Yan S; Yin Y; Hou J; Wang X; Sun B
Tumour Biol; 2014 Oct; 35(10):10267-73. PubMed ID: 25034527
[TBL] [Abstract][Full Text] [Related]
9. Toll-like receptor-4 agonist inhibits motility and invasion of hepatoblastoma HepG2 cells in vitro.
Hsiao CC; Kao YH; Huang SC; Chuang JH
Pediatr Blood Cancer; 2013 Feb; 60(2):248-53. PubMed ID: 22648929
[TBL] [Abstract][Full Text] [Related]
10. Novel chemokine-like activities of histones in tumor metastasis.
Chen R; Xie Y; Zhong X; Fu Y; Huang Y; Zhen Y; Pan P; Wang H; Bartlett DL; Billiar TR; Lotze MT; Zeh HJ; Fan XG; Tang D; Kang R
Oncotarget; 2016 Sep; 7(38):61728-61740. PubMed ID: 27623211
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of the proliferation and invasion of hepatocellular carcinoma cells by lipocalin 2 through blockade of JNK and PI3K/Akt signaling.
Lee EK; Kim HJ; Lee KJ; Lee HJ; Lee JS; Kim DG; Hong SW; Yoon Y; Kim JS
Int J Oncol; 2011 Feb; 38(2):325-33. PubMed ID: 21132267
[TBL] [Abstract][Full Text] [Related]
12. [Hepatitis B core antigen promotes invasion of hepatocellular carcinoma cell line HepG2.2.15 via Toll-like receptor 4].
Hou HR; Kang Y; Li YK; Zeng YL; Wei JF; Ding GG; Peng Z; Shang J
Zhonghua Gan Zang Bing Za Zhi; 2017 Dec; 25(12):908-913. PubMed ID: 29325291
[No Abstract] [Full Text] [Related]
13. CXC195 suppresses proliferation and inflammatory response in LPS-induced human hepatocellular carcinoma cells via regulating TLR4-MyD88-TAK1-mediated NF-κB and MAPK pathway.
Wang Y; Tu Q; Yan W; Xiao D; Zeng Z; Ouyang Y; Huang L; Cai J; Zeng X; Chen YJ; Liu A
Biochem Biophys Res Commun; 2015 Jan; 456(1):373-9. PubMed ID: 25475726
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effects of alternaramide on inflammatory mediator expression through TLR4-MyD88-mediated inhibition of NF-кB and MAPK pathway signaling in lipopolysaccharide-stimulated RAW264.7 and BV2 cells.
Ko W; Sohn JH; Jang JH; Ahn JS; Kang DG; Lee HS; Kim JS; Kim YC; Oh H
Chem Biol Interact; 2016 Jan; 244():16-26. PubMed ID: 26620692
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide enhances decorin expression through the Toll-like receptor 4, myeloid differentiating factor 88, nuclear factor-kappa B, and mitogen-activated protein kinase pathways in odontoblast cells.
He W; Qu T; Yu Q; Wang Z; Wang H; Zhang J; Smith AJ
J Endod; 2012 Apr; 38(4):464-9. PubMed ID: 22414830
[TBL] [Abstract][Full Text] [Related]
16. Licochalcone A suppresses migration and invasion of human hepatocellular carcinoma cells through downregulation of MKK4/JNK via NF-κB mediated urokinase plasminogen activator expression.
Tsai JP; Hsiao PC; Yang SF; Hsieh SC; Bau DT; Ling CL; Pai CL; Hsieh YH
PLoS One; 2014; 9(1):e86537. PubMed ID: 24466137
[TBL] [Abstract][Full Text] [Related]
17. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol.
Jakus PB; Kalman N; Antus C; Radnai B; Tucsek Z; Gallyas F; Sumegi B; Veres B
J Nutr Biochem; 2013 May; 24(5):819-23. PubMed ID: 22925919
[TBL] [Abstract][Full Text] [Related]
18. Sophocarpine attenuates toll-like receptor 4 in steatotic hepatocytes to suppress pro-inflammatory cytokines synthesis.
Song CY; Zeng X; Wang Y; Shi J; Qian H; Zhang Y; Fang JQ; Sheng X; Zheng JM; Chen YX
J Gastroenterol Hepatol; 2015 Feb; 30(2):405-12. PubMed ID: 25089018
[TBL] [Abstract][Full Text] [Related]
19. High expression of IL-4R enhances proliferation and invasion of hepatocellular carcinoma cells.
Guo C; Ouyang Y; Cai J; Xiong L; Chen Y; Zeng X; Liu A
Int J Biol Markers; 2017 Oct; 32(4):e384-e390. PubMed ID: 28665449
[TBL] [Abstract][Full Text] [Related]
20. LPS induces IL-8 expression through TLR4, MyD88, NF-kappaB and MAPK pathways in human dental pulp stem cells.
He W; Qu T; Yu Q; Wang Z; Lv H; Zhang J; Zhao X; Wang P
Int Endod J; 2013 Feb; 46(2):128-36. PubMed ID: 22788664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
